| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
2.36 0.01 (0%) |
02-21 15:16 |
|
Open: |
2.38 |
Pre close: |
2.35 |
Target:
|
2.96
|
|
High: |
2.4 |
Low: |
2.33 |
Resistance:
|
2.53
2.96
|
|
Volume: |
435,652 |
Market Cap: |
393M |
Support:
|
2.18
1.97
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.35
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
2.22 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
2.62  |
Stochastic Oscillator |
%K(14,3):
|
63.23 |
|
MA(250): |
3.09 |
%D(3): |
74.47 |
|
Average Volume(K) |
3-Month: |
238429
|
52-Week |
High:
|
4.68 |
|
10-Days: |
128364 |
Low: |
1.96 |
|
RSI |
RSI(14):
|
54.43 |
Change(%): |
-37.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.650 |
Return on Equity (ttm) |
-125.2 |
Shares Out. (M) |
166.64 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-102.8 |
Shares Float (M) |
165.97 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.08 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
440.6 |
% Held by Institutions |
143.60 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.620 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.58 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.64 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-90.19 |
P/S |
9706779648.00 |
|
Operating Margin |
-1524.81 |
Levered Free Cash Flow
(M) |
-54.46 |
P/CF |
-4.31 |
|
|
|
|
|
|
